The International Tennis Integrity Agency (ITIA) today confirms that Imran Sibille, a 23-year-old tennis player from Morocco, has been provisionally suspended under the Tennis Anti-Doping Programme (TADP).
The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 8 May 2025 under Article 2.1 of the TADP (presence of a Prohibited Substance in a Player’s Sample) and/or Article 2.2 (Use of a Prohibited Substance without a valid Therapeutic Use Exemption (TUE)).
Sibille, who reached a career-high world singles ranking of 1433 in January 2024, provided an in-competition sample while competing in an ITF World Tennis Tour M25 event in Catalonia, Spain, on 9 March 2025.
The sample was split into A and B samples and the subsequent analysis found that the A sample contained cocaine (and its metabolites), which is prohibited under the TADP, in the category of Stimulants (section S 6.A of the 2025 World Anti-Doping Agency Prohibited List).
Cocaine is a non-Specified substance. Findings for non-Specified Substances carry a mandatory provisional suspension – in Sibille’s case, this has been in effect from 8 May 2025. Players have the right to appeal the imposition of their provisional suspension before an independent tribunal chair. To date, Sibille has not appealed.
While provisionally suspended, Sibille is prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.
The ITIA is an independent body established by its tennis members to promote, encourage, enhance, and safeguard the integrity of professional tennis worldwide.
Ends
Published 19 May 2025 14:00
